BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30138374)

  • 1. Risk factors for diagnosed noma in northwest Nigeria: A case-control study, 2017.
    Farley E; Lenglet A; Ariti C; Jiya NM; Adetunji AS; van der Kam S; Bil K
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006631. PubMed ID: 30138374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of noma (cancrum oris) and its risk factors in Northwestern Nigeria: A hospital-based retrospective study.
    Adeniyi SA; Awosan KJ
    Ann Afr Med; 2019; 18(1):17-22. PubMed ID: 30729928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of noma in northwest Nigeria.
    Farley E; Oyemakinde MJ; Schuurmans J; Ariti C; Saleh F; Uzoigwe G; Bil K; Oluyide B; Fotso A; Amirtharajah M; Vyncke J; Brechard R; Adetunji AS; Ritmeijer K; van der Kam S; Baratti-Mayer D; Mehta U; Isah S; Ihekweazu C; Lenglet A
    BMJ Glob Health; 2020; 5(4):e002141. PubMed ID: 32377404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proportion of paediatric admissions with any stage of noma at the Anka General Hospital, northwest Nigeria.
    Farley E; Karinja MN; Lawal AM; Olaleye M; Muhammad S; Umar M; Gaya FK; Mbaeri SC; Sherlock M; Kabila DW; Peters M; Samuel J; Maloba G; Usman R; van der Kam S; Ritmeijer K; Ariti C; Amirtharajah M; Lenglet A; Falq G
    PLoS Negl Trop Dis; 2023 Oct; 17(10):e0011508. PubMed ID: 37889919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for noma disease: a 6-year, prospective, matched case-control study in Niger.
    Baratti-Mayer D; Gayet-Ageron A; Hugonnet S; François P; Pittet-Cuenod B; Huyghe A; Bornand JE; Gervaix A; Montandon D; Schrenzel J; Mombelli A; Pittet D;
    Lancet Glob Health; 2013 Aug; 1(2):e87-e96. PubMed ID: 25104163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of cases of cancrum oris seen in Ile-Ife, Nigeria.
    Oginni FO; Oginni AO; Ugboko VI; Otuyemi OD
    Int J Paediatr Dent; 1999 Jun; 9(2):75-80. PubMed ID: 10530215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and associated risk factors for noma in Nigerian children: a systematic review and meta-analysis.
    Eleje GU; Okoh EE; Igbodike EP; Akinsolu FT; Nwaokorie FO; Lusher JM; Tantawi ME; Salako AO; Ezechi OC; Foláyan MNO
    BMC Oral Health; 2024 Jun; 24(1):685. PubMed ID: 38867180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Language and beliefs in relation to noma: a qualitative study, northwest Nigeria.
    Farley E; Lenglet A; Abubakar A; Bil K; Fotso A; Oluyide B; Tirima S; Mehta U; Stringer B
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007972. PubMed ID: 31971944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'I treat it but I don't know what this disease is': a qualitative study on noma (cancrum oris) and traditional healing in northwest Nigeria.
    Farley E; Bala HM; Lenglet A; Mehta U; Abubakar N; Samuel J; de Jong A; Bil K; Oluyide B; Fotso A; Stringer B; Cuesta JG; Venables E
    Int Health; 2020 Jan; 12(1):28-35. PubMed ID: 31504549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An estimation of the incidence of noma in north-west Nigeria.
    Fieger A; Marck KW; Busch R; Schmidt A
    Trop Med Int Health; 2003 May; 8(5):402-7. PubMed ID: 12753633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrotizing ulcerative gingivitis and cancrum oris (noma) in Ibadan, Nigeria.
    Osuji OO
    J Periodontol; 1990 Dec; 61(12):769-72. PubMed ID: 2269918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noma: a neglected scourge of children in sub-Saharan Africa.
    Enwonwu CO
    Bull World Health Organ; 1995; 73(4):541-5. PubMed ID: 7554028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Characterization of Noma Cases Found Incidentally across Nigeria during Outreach Programs for Cleft Lip from 2011-2020.
    Ver-Or N; Iregbu CK; Taiwo OO; Afeleokhai IT; Aza CG; Adaji JZ; Margima C
    Am J Trop Med Hyg; 2022 Nov; 107(5):1132-1136. PubMed ID: 36216317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancrum oris: its incidence and treatment in Enugu, Nigeria.
    Oji C
    Br J Oral Maxillofac Surg; 2002 Oct; 40(5):406-9. PubMed ID: 12379187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Noma/Cancrum oris: a neglected disease].
    García-Moro M; García-Merino E; Martín-Del-Rey A; García-Sánchez E; García-Sánchez JE
    Rev Esp Quimioter; 2015 Oct; 28(5):225-34. PubMed ID: 26437752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living conditions of children at risk for noma: Nigerian experience.
    Idigbe EO; Enwonwu CO; Falkler WA; Ibrahim MM; Onwujekwe D; Afolabi BM; Savage KO; Meeks VI
    Oral Dis; 1999 Apr; 5(2):156-62. PubMed ID: 10522214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Noma: 'the face of poverty'].
    Marck KW; Spijkervet FK
    Ned Tijdschr Tandheelkd; 2001 Dec; 108(12):496-9. PubMed ID: 11795097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noma, a neglected disease: prevention is better than cure.
    Farley E; Amirtharajah M; Shaye DA
    Curr Opin Otolaryngol Head Neck Surg; 2022 Aug; 30(4):219-225. PubMed ID: 35906973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reviewing trends in the incidence of cancrum oris in Ibadan, Nigeria.
    Denloye OO; Aderinokun GA; Lawoyin JO; Bankole OO
    West Afr J Med; 2003; 22(1):26-9. PubMed ID: 12769302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of noma cases in a tertiary hospital located in a conflict endemic region in Nigeria.
    Owobu T; Ojukwu BT; Azah OO; Sulaiman SA; Halilu M; Nnawuihe UC; Sanni AB
    Med Confl Surviv; 2022 Dec; 38(4):295-306. PubMed ID: 36003023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.